| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.29 | 0.09 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |